Your browser doesn't support javascript.
loading
Comparison of Balloon Guide Catheters and Standard Guide Catheters for Acute Ischemic Stroke: An Updated Systematic Review and Meta-analysis.
Pederson, John M; Hardy, Nicole; Lyons, Hannah; Sheffels, Erin; Touchette, Jillienne C; Brinjikji, Waleed; Kallmes, David F; Kallmes, Kevin M.
Afiliación
  • Pederson JM; Superior Medical Experts, St. Paul, Minnesota, USA; Nested Knowledge, Inc, St. Paul, Minnesota, USA. Electronic address: jpederson@supedit.com.
  • Hardy N; Superior Medical Experts, St. Paul, Minnesota, USA.
  • Lyons H; Superior Medical Experts, St. Paul, Minnesota, USA.
  • Sheffels E; Superior Medical Experts, St. Paul, Minnesota, USA.
  • Touchette JC; Superior Medical Experts, St. Paul, Minnesota, USA.
  • Brinjikji W; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kallmes DF; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kallmes KM; Superior Medical Experts, St. Paul, Minnesota, USA; Nested Knowledge, Inc, St. Paul, Minnesota, USA.
World Neurosurg ; 185: 26-44, 2024 05.
Article en En | MEDLINE | ID: mdl-38296042
ABSTRACT

OBJECTIVE:

The objective of this study was to update our 2021 systematic review and meta-analysis which reported that balloon guide catheters (BGC) are associated with superior clinical and angiographic outcomes compared to standard guide catheters for treatment of acute ischemic stroke.

METHODS:

We conducted a systematic review of 7 electronic databases to identify literature published between January 2010 and September 2023 reporting BGC versus non-BGC approaches. Primary outcomes were final modified thrombolysis in cerebral infarction (mTICI) ≥2b, first-pass effect (mTICI ≥2c on first pass), and modified Rankin scale 0-2 at 90 days. The risk of bias was assessed using the Newcastle Ottawa Scale. A separate random effects model was fitted for each outcome. Subgroup analyses by first-line approach were conducted.

RESULTS:

Twenty-four studies comprising 8583 patients were included (4948 BGC; 3635 non-BGC; 1561 BGC + Stent-retriever; 1297 non-BGC + Stent-retriever). Nine studies had low risk of bias, 3 were moderate risk, and 12 were high risk. Patients treated with BGCs had higher odds of achieving mTICI 2b/3, first-pass effect mTICI 2c/3, and modified Rankin scale 0-2 at 90 days (P < 0.001). The number of patients needed to treat in order to achieve one additional successful recanalization is 17. BGC + Stent-retriever was associated with higher odds of mTICI≥2b, 90-day modified Rankin scale 0-2, and reduced odds of 90-day mortality compared to non-BGC + Stent-retrievers. The main limitation was the absence of randomized trials.

CONCLUSIONS:

These findings corroborate our previous results suggesting that MT using BGCs is associated with better safety and effectiveness outcomes for acute ischemic stroke, especially BGC + Stent-retrievers.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article